3 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
The Objective of the Protocol is to Generate Real World Evidence (RWE) Supporting the Safety, Performance, and Health Economics of Using the Regulatory Approved and Commercially Available EARP Interbody System Used During Lumbar Interbody Fusion (LIF) Procedures With the EARP Nerve Cuff ElectrodeTransforaminal Lumbar Interbody Fusion SurgeryRecruitingNot stated2026-10-06NCT07020000
REACTION (Radiation Enhanced Assessment of Combination Therapies in Immuno-ONcology) - Nivolumab or Nivolumab in Combination With Other Immuno-oncology (IO) Agents After Targeted Systemic Radiation in Patients With Advanced Esophagogastric Cancergastroesophageal cancerActive, not recruitingPhase 1 / Phase 22026-05-06NCT03610711
Nivolumab +/- Relatlimab Prior to Chemoradiation With II/III Gastro/Esophageal CancerDigestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, esophageal cancer, esophageal disorder, gastric cancer, gastric neoplasm, gastroesophageal cancer, neoplasm, stomach disorderActive, not recruitingPhase 12026-03-23NCT03044613